Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

NUVATION BIO INC.

(NUVB)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/13/2021 09/14/2021 09/15/2021 09/16/2021 09/17/2021 Date
9.33(c) 9.59(c) 9.76(c) 10(c) 9.65(c) Last
1 108 719 523 113 762 357 954 565 6 476 160 Volume
-0.11% +2.79% +1.77% +2.46% -3.50% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 - - -
Net income 2021 -87,1 M - -
Net Debt 2021 - - -
P/E ratio 2021 -21,8x
Yield 2021 -
Sales 2022 - - -
Net income 2022 -127 M - -
Net Debt 2022 - - -
P/E ratio 2022 -15,8x
Yield 2022 -
Capitalization 2 101 M 2 101 M -
Capi. / Sales 2021 -
Capi. / Sales 2022 -
Nbr of Employees 51
Free-Float 72,5%
More Financials
Company
Nuvation Bio, Inc, formerly Panacea Acquisition Corp, is a biopharmaceutical company. The Company is engaged in developing differentiated and novel therapeutic candidates. Its portfolio includes distinct oncology therapeutic product candidates, each targeting some of the difficult-to-treat types of cancer. The Company’s drug discovery and development programs include a cyclin-dependent kinase (CDK) inhibitor... 
More about the company
Ratings of Nuvation Bio Inc.
Trading Rating : 
Investor Rating :  -
ESG Refinitiv : 
-
More Ratings
All news about NUVATION BIO INC.
08/13NUVATION BIO : Wedbush Adjusts Nuvation Bio's Price Target to $23 From $21, Keep..
MT
08/12NUVATION BIO : Ongoing enrollment in Phase 1/2 study of lead investigational com..
PU
08/12NUVATION BIO : Reports Second Quarter 2021 Financial Results and Provides Busine..
PR
08/12Nuvation Bio Inc. Reports Condensed Earnings Results for the Second Quarter a..
CI
06/21NUVATION BIO INC.(NYSE : NUVB) added to S&P Global BMI Index
CI
06/21NUVATION BIO INC.(NYSE : NUVB) added to S&P Pharmaceuticals Select Industry Inde..
CI
06/04Nuvation Bio Inc. Announces Resignation of Michelle Doig from the Board of Di..
CI
06/01NUVATION BIO : Appoints David C. Hanley, Ph.D., as Chief Technical Operations Of..
PR
06/01Nuvation Bio Appoints David C. Hanley, as Chief Technical Operations Officer
CI
05/26NUVATION BIO : to Participate in the Jefferies Virtual Healthcare Conference
PR
05/21NUVATION BIO : Amendment to Annual Report (SEC Filing - 10-K/A)
PU
05/18NUVATION BIO : Wedbush Adjusts Nuvation Bio's Price Target to $21 From $20, Keep..
MT
05/17NUVATION BIO : Reports First Quarter 2021 Financial Results and Provides Busines..
PU
05/17NUVATION BIO : Reports First Quarter 2021 Financial Results and Provides Busines..
PR
05/17Nuvation Bio Inc. Announces Consolidated Earnings Results for the Year Ended ..
CI
More news
News in other languages on NUVATION BIO INC.

- No features available -

More news
Analyst Recommendations on NUVATION BIO INC.
More recommendations
Chart NUVATION BIO INC.
Duration : Period :
Nuvation Bio Inc. Technical Analysis Chart | NUVB | US67080N1019 | MarketScreener
Technical analysis trends NUVATION BIO INC.
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 9,65 $
Average target price 18,20 $
Spread / Average Target 88,6%
EPS Revisions
Managers and Directors
David T. Hung President, CEO & Director
Jennifer Fox Chief Financial Officer
Daniel G. Welch Chairman
Sergey Yurasov Chief Medical Officer
Gary Hattersley Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
NUVATION BIO INC.-17.52%2 101
MODERNA, INC.311.65%173 588
LONZA GROUP AG32.35%60 074
IQVIA HOLDINGS INC.43.07%49 116
CELLTRION, INC.-23.26%31 904
SEAGEN INC.-10.81%28 420